SCN1A and epilepsy: Increased INaP is associated with mutations in SCN1A that have been identified from individuals with epilepsy (Meisler and Kearney, 2005) and is specifically reduced by AEDs such as phenytoin, valproate and lamotrigine (Stafstrom, 2007).